IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION
1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day).
LOW DOSE: ≤ 0.5 mg/kg/day
**Best for:**
- Cancers in remission
- Strong family history or genetic predisposition
- Prophylaxis (preventive)
**Side effects:** No long-term side effects reported.
**Example:** Dr. Tess Lawrie reported a Stage 3 ovarian cancer case treated with chemo + 12 mg ivermectin daily. Tumor marker CA125 dropped from 288 to 22 after 2 months and the tumor vanished.
MEDIUM DOSE: 1.0 mg/kg/day
**Best for:** Starting dose for **most cancers** (lung, pancreatic, renal cell, gastric, etc.).
**Side effects:** No long-term side effects reported.
**Example:** Dr. Shankara Chetty’s 70-year-old prostate cancer patient (PSA 89) took 45 mg/day (plus lactoferrin). After two months PSA fell to 10.9.
HIGH DOSE: 2.0 mg/kg/day
**Best for:** Very aggressive cancers (leukemia, pancreatic, brain cancers).
**Side effects:** No long-term side effects reported.
**Example:** Dr. Allan Landrito’s Stage 4 gallbladder cancer patient took 2 mg/kg daily for 14 months — cancer disappeared.
VERY HIGH DOSE: ≥ 2.5 mg/kg/day
**Best for:** Extensive metastatic disease, extremely poor prognosis, or certain brain cancers.
**Side effects:** Possible short-term & transient visual effects (usually resolve in a few days).
**Example:** Dr. Shankara Chetty treated a patient with 2.5 mg/kg/day — no side effects reported.
**Quick conversion example (for a 60 kg / 132 lb person):**
- Low: ≤30 mg/day
- Medium: 60 mg/day (≈5×12 mg tablets or 1 teaspoon liquid)
- High: 120 mg/day
- Very High: ≥150 mg/day
Many anecdotal reports exist of long-term daily use (months to over a year) with no serious toxicity, but individual responses vary.
Always work with a knowledgeable clinician, especially if you have pre-existing conditions (e.g., vision issues or glaucoma). This is for educational purposes only.
Share to spread awareness — information is power. 💊
Mebendazole and Ivermectin should be over-the-counter — affordable and accessible to everyone.
Dr. John Campbell reacted to an ivermectin cancer study by saying, “We could be curing cancer with ivermectin and mebendazole.”
Visit:- https://t.co/cxBZ8Fyu6y
#ivermectin #mebendazole #CancerResearch
NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial - 65 year old GEORGIA man with Stage 4 Pancreatic Cancer reports after 3 months: tumor shrinkage!
Beating Stage 4 Pancreatic Cancer is the best! 😃
STORY:
65 year old GEORGIA man with Stage 4 Pancreatic Cancer
Diagnosed April 2025, confirmed metastatic to lymph nodes and liver by PET/CT in August 2025
In September 2025 he started:
Ivermectin 1mg/kg/day
Fenbendazole 1500 mg/day
Chemo
Results after 3 months:
“latest CT scan shows 50% reduction in pancreas mass and liver metastasis areas since September- chemo along with Fenbendazole.”
“Oncologist said results are much better than expected and new treatment options opening.”
“Will keep on with the Fenben. Unable to tolerate Ivermectin unfortunately.”
Not everyone can tolerate Ivermectin but that doesn’t mean you are out of options in terms of repurposed drugs.
"Oncologist said results are much better than expected" - they will give their honest assessment if they are not aware of what's actually going on.
"New Treatment options opening" - in Pancreatic Cancer, this usually means an inoperable tumor has now become operable.
I have helped over 9000 Cancer patients with Ivermectin, Mebendazole and Fenbendazole in the largest Ivermectin Cancer Project in the world.
This Ivermectin Cancer Project is now moving to FLORIDA!
A New Florida Cancer Clinic is being prepared, and it will revolutionize Cancer Care in the United States (please be patient, it will be operational soon!)
Article link in first photo at the top to avoid shadowbanning on X (it still happens), just retype the URL into your browser.
🚨 After a year of intensive research, Dr. William Makis presents what he calls the most critical graph of his career: the ivermectin dosing schedule for cancer.
@Ivermectincure
According to Dr. Makis, for most cancers — including breast, colon, lung, pancreatic, renal, gastric cancers, and leukemias — a starting dose of 1 mg per kg of body weight per day is recommended.
For a 60 kg individual, this equates to 60 mg daily:
• Five 12 mg pills
• Or 6 mL of liquid (approximately one teaspoon plus 1 mL)
The evidence for efficacy is described as compelling and dose-dependent:
• Dr. Shankara Chetty reportedly observed a prostate cancer patient’s PSA level drop from 89 to 11 on 45 mg/day.
• A case shared by Dr. Tess Lawrie showed CA-125 (an ovarian cancer marker) dropping from 288 to 22 on just 0.2 mg/kg.
• A long-term Castro study involving children with leukemia reportedly found no side effects after six months at 1 mg/kg.
For aggressive cancers (such as pancreatic or brain cancer), the blood-brain barrier may require higher doses. Dr. Makis cites:
• Dr. Landrito’s colleague with terminal gallbladder cancer, whose cancer reportedly disappeared after 14 months at 2 mg/kg/day.
The highest documented dose mentioned is 2.5 mg/kg (by Dr. Chetty), with only transient visual side effects that reportedly resolved.
Mainstream oncology does not currently offer this treatment. Supporters argue this is because ivermectin is generic, off-patent, and unprofitable, resulting in limited funding for large clinical trials.
Dr. Makis’s conclusion:
“Using ivermectin in cancer is honestly very straightforward. It is a very, very safe drug.”
His strong suggestion for those struggling: start at 1 mg/kg/day. According to anecdotal reports, it can be taken for many months — even over a year — with an excellent safety profile.
The power to fight may already be on your shelf.
Visit: https://t.co/REwGZCdhg9
#CancerResearch #Ivermectin #Fenbendazole
Mel Gibson isn't lying... our new study found 84% of cancer patients taking ivermectin + mebendazole declared either COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH after 6 months.
🚨 DR. WILLIAM MAKIS’ IVERMECTIN DOSING GUIDE FOR CANCER & PREVENTION IS SPREADING FAST ONLINE
Thousands are now discussing Dr. William Makis MD’s categorized Ivermectin dosing approach based on body weight (mg/kg/day) and cancer severity.
Here’s the breakdown people keep sharing:
LOW DOSE: ≤ 0.5 mg/kg/day
Often discussed for:
• Remission support
• Prevention strategies
• Strong family cancer history
⚠️ Reports shared online describe minimal long term side effects at lower ranges.
Access them via @Pharmacyinusa
MEDIUM DOSE: 1.0 mg/kg/day
Most commonly discussed for:
• Breast cancer
• Lung cancer
• Colon cancer
• Pancreatic cancer
• Renal cancers
⚠️ Supporters claim this is the “standard starting range” used in many repurposed drug discussions.
HIGH DOSE: 2.0 mg/kg/day
Typically discussed for:
• Aggressive cancers
• Leukemia
• Pancreatic cancer
• Brain cancers
⚠️ Some anecdotal reports mention temporary visual side effects at higher dosing ranges.
VERY HIGH DOSE: ≥ 2.5 mg/kg/day
Usually discussed only for:
• Advanced metastatic disease
• Late stage aggressive cancers
⚠️ High dose use remains highly controversial and experimental.
Quick weight example for a 60 kg (132 lb) adult:
• Low: 30 mg/day
• Medium: 60 mg/day
• High: 120 mg/day
• Very High: 150+ mg/day
Why this conversation keeps exploding online:
✅ Ivermectin has decades of human use worldwide
✅ Growing interest in repurposed cancer drugs
✅ Observational and preclinical research continues expanding
✅ Patients are increasingly sharing personal experiences publicly. (Jase Medical)
Still, millions are now asking why inexpensive repurposed drugs are generating so much public interest while receiving so little mainstream discussion.
**The chart has been upscaled for better visibility**
#Ivermectin #Fenbendazole #Mebendazole
NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial - 73 year old woman in NORTHERN IRELAND with Stage 4 Small Cell Lung Cancer reports after 3 months: 50% tumor shrinkage!
Ivermectin Cancer Revolution comes to Northern Ireland! 😃
STORY:
73 year old woman in NORTHERN IRELAND with Stage 4 Small Cell Lung Cancer
In January 2026 she started:
Ivermectin 1mg/kg/day
Fenbendazole 1500mg/day
Chemo (carboplatin and etoposide)
Results after 3 months: “50% reduction in primary tumor size with no spread or increase in secondaries!”
COMMENT:
Small Cell Lung Cancer is one of the most aggressive cancers known to mankind.
While it is difficult in countries like Northern Ireland to get repurposed drugs, cancer patients find a way! 😃
I have helped over 9000 Cancer patients with Ivermectin, Mebendazole and Fenbendazole in the largest Ivermectin Cancer project in the world.
This Ivermectin Cancer Project is now moving to FLORIDA!
A New Florida Cancer Clinic is forming and it will revolutionize Cancer Care in the United States.
Article link in first photo at the top to avoid shadowbanning on X (yes it still happens).
🧬 IVERMECTIN and Breast Cancer
💊 Some researchers have explored whether ivermectin may affect breast cancer stem cells in laboratory studies. However, ivermectin is not an approved treatment for breast cancer, and more clinical research is needed to determine its safety and effectiveness in humans.
👉@ivermectincure
A 2017 study from researchers in Mexico City explored an important question:
Could ivermectin affect breast cancer stem cells?
Here’s what the study suggested. 👇
1️⃣ The study, “Ivermectin as an Inhibitor of Cancer Stem Cells,” examined ivermectin in laboratory models of breast cancer.
2️⃣ Researchers investigated whether the drug could interfere with cancer stem cells — a small group of cells believed to contribute to tumor growth, treatment resistance, and recurrence.
3️⃣ In their experiments, ivermectin appeared to affect signaling pathways associated with these cells.
4️⃣ Scientists have been exploring the potential anti-cancer effects of ivermectin in research settings since the 1990s.
5️⃣ However, findings from cell or animal studies do not automatically translate into effective treatments for patients.
6️⃣ Before any drug can become a cancer therapy, it must undergo rigorous human clinical trials to establish safety and effectiveness.
7️⃣ As of today, ivermectin is not an approved treatment for breast cancer, and oncology guidelines do not recommend it for this use.
8️⃣ Still, research like this helps scientists explore new directions for understanding and targeting cancer.
Visit:- https://t.co/REwGZCdhg9
Science advances step by step. 🧬
#CancerResearch #Ivermectin #BreastCancer
🧬 Fenbendazole: A Potential Area of Cancer Research
Some people claim that when conventional chemotherapy failed, Fenbendazole helped certain terminal cancer patients achieve remission. It is considered affordable, generally well-tolerated, and difficult to patent, which some believe has limited large-scale pharmaceutical investment. However, Fenbendazole is not an approved cancer treatment, and scientific evidence for its effectiveness in humans is still limited.
Imagine cancer cells as a factory. Fenbendazole is believed to disrupt the “power supply” and damage the “conveyor belts,” potentially slowing the machinery that drives cancer growth. Supporters suggest that healthy cells may be less affected compared to traditional chemotherapy, which can damage both healthy and cancerous cells.
This is why Fenbendazole has gained attention as a possible area of cancer research, though more clinical studies are needed to confirm its safety and effectiveness.
Visit: 👉https://t.co/REwGZCdhg9
#Fenbendazole #Ivermectin #CancerResearch
💊 Ivermectin & Fenbendazole: How They Work Together
Ivermectin and fenbendazole are both antiparasitic drugs (anthelmintics), but they work through different mechanisms and target different areas of the body. When used strategically—whether in rotation or combination—they are sometimes discussed for broader antiparasitic coverage.
🧬 Ivermectin
Mechanism: Binds to glutamate-gated chloride channels in parasite nerve and muscle cells, causing paralysis and death.
Targets: Blood parasites, filarial worms, lice, mites, and some gastrointestinal worms.
Strengths: Penetrates multiple tissues, including the lungs, skin, and, under certain conditions, the central nervous system.
Best suited for: Systemic parasitic infections affecting the blood, skin, lungs, and nervous system.
🪱 Fenbendazole
Mechanism: Disrupts microtubule formation by binding to beta-tubulin, preventing parasite cells from absorbing nutrients and reproducing.
Targets: Primarily gastrointestinal parasites such as roundworms, hookworms, whipworms, and some tapeworms.
Strengths: Acts mainly within the digestive tract and interferes with parasite metabolism.
Best suited for: Intestinal parasitic infections.
✨ Why Are They Discussed Together?
• Broader coverage: May target a wider range of parasites across different tissues.
• Reduced resistance risk: Different mechanisms may lower the chance of parasite adaptation.
• Complementary action: Ivermectin acts systemically, while fenbendazole works primarily in the gut.
• Potential synergy: Some suggest one may enhance the effectiveness of the other, although scientific evidence is limited.
🚨 Important Considerations (Medical Guidance Recommended)
• Cycles are sometimes discussed (e.g., 3–5 days on/off or weekly rotation), but protocols vary.
• Some individuals use binders such as activated charcoal or bentonite clay, though evidence is limited.
• Liver and kidney function should be monitored under professional supervision.
• Maintain proper hydration and electrolyte balance.
• These medications should only be used under the guidance of a qualified healthcare professional.
Visit 👉 https://t.co/EeKlejJcj8
#Ivermectin #Fenbendazole #Detox #Parasites #CancerResearch
MEBENDAZOLE Patent for Treatment of CANCER
Mebendazole is sometimes called an “animal dewormer” like Ivermectin and Fenbendazole.
On Sep.7, 2021, Johns Hopkins University in Baltimore, MD secured a patent for MEBENDAZOLE for this use:
1. Repurposed for Glioblastoma Therapy
(as an oral drug mebendazole polymorph C is a superior form, and it reaches the brain and brain tumors in effective concentrations)
2. Mebendazole may also be used for therapy of other cancers, as well as a chemo-preventative agent.
Patent No. US 11,110,079 B2
Date of Patent: Sep.7, 2021
The title of the patent: “Mebendazole Polymorph for Treatment and Prevention of Tumors”
Applicant: Johns Hopkins University
Inventors: Gregory Riggins, et al
I will let this sink in.
This is what I have been working with for the past 2 years, in the largest Ivermectin Cancer Project in the world. 9000+ Cancer patients.
You have never seen this patent in the news.
You have never seen any Oncologist talk about this patent.
Yet, this is a game changer for Glioblastoma Cancer patients.
🚨 Patriot Cancer Protocol 🚨
@_Ivermectincure
A united effort by individuals committed to exploring alternative perspectives on wellness, empowering one another through shared knowledge, and seeking truth in every path to healing.
This initiative brings together people who believe in informed choice, personal freedom, and the strength of community support. Through collaboration, research, open discussion, and real-world experiences, we aim to highlight options, encourage critical thinking, and support the right to pursue comprehensive, holistic approaches to health.
Together, we grow stronger, more informed, and more determined than ever. 💪
Visit: https://t.co/cxBZ8FxWh0
#CancerProtocol #Ivermectin #Fenbendazole
🚨 Protocol for Cancer – Ivermectin & Fenbendazole Dosing
@ivermectincure
Overview (for informational purposes only):
Several emerging research discussions are exploring the potential roles of antiparasitic agents—such as ivermectin and fenbendazole—in cancer-related metabolic pathways. These regimens are not approved cancer treatments and should only be considered within controlled research settings or under medical supervision.
Example Investigational Dosing Frameworks (not medical guidance):
Low Range:
Ivermectin ≤ 0.5 mg/kg | Fenbendazole 222 mg, 3 times per week
Medium Range:
Ivermectin 1.0 mg/kg | Fenbendazole 222 mg daily (6 days/week)
High Range:
Ivermectin 2.0 mg/kg | Fenbendazole 444 mg daily (6 days/week)
Very High Range:
Ivermectin ≥ 2.5 mg/kg | Fenbendazole 888–1000 mg daily (6 days/week)
Visit:- https://t.co/cxBZ8Fyu6y
#CancerCures #Ivermectin #Fenbendazole #CancerResearch #Cancer
https://t.co/HL7MwWre2Z
🚨 CANCER PATIENTS SEE 32% TUMOR GROWTH REDUCTION
32.8% — no evidence of disease
15.6% — tumour regression
So why isn’t this headline news?
Watch this.
@twc_health@alejandrodiazmd
COMPLETE REMISSIONS of Stage IV cancers using anti-parasitics are now being documented in the peer-reviewed literature.
HUNDREDS of studies show ivermectin and mebendazole exert over 12 distinct anti-cancer mechanisms across more than 12 cancer types.
A recent study found intranasal nano-ivermectin shrinks glioblastoma brain tumors by 70% in just 10 days in rats — with ZERO toxicity.
IVERMECTIN DOSING
A growing number of people are referencing dosing frameworks shared by William Makis for off-label ivermectin use in cancer discussions. Here it is. 👇
CURED his mother's cancer!
JOE TIPPENS PROTOCOL - FENBENDAZOLE - PARASITES AND CANCER TREATMENT
Fenbendazole (222mg)
Vitamin E (800IU daily)
Curcumin (600mg daily)
CBD oil (25mg per day)
Berberine & Quercetine
The NIH has known about this cure for decades!
Dr. Lee Merritt: “Cancer under the light microscope is essentially indistinguishable from parasite egg sacks.”Doctors worldwide are showing it’s intracellular parasites. German study in the 90s proved it.